Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Inner Mongolia Buchang Pharmaceutical is a subsidiary of Shandong Buchang Pharmaceuticals, a leading Chinese pharmaceutical company specializing in Traditional Chinese Medicine (TCM). The company focuses on the production and development of herbal-based treatments for cardiovascular and cerebrovascular conditions. Its operations are centered in Inner Mongolia, where it utilizes modern manufacturing technologies to produce standardized TCM products. Key products associated with the Buchang group include Danhong Injection and Wenxin Keli, which are prominent in the Chinese domestic market for heart and brain health. The company plays a vital role in the parent group's supply chain and manufacturing strategy, adhering to Good Manufacturing Practice (GMP) standards to ensure the quality and safety of its botanical extracts.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Inner Mongolia Buchang Pharmaceutical.